Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.

The macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either locali...

Full description

Bibliographic Details
Main Authors: Marian Seif, Michael L Impelido, Michael G Apps, Nial J Wheate
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3893214?pdf=render
id doaj-c4d502fea09a40baab3033767d962e38
record_format Article
spelling doaj-c4d502fea09a40baab3033767d962e382020-11-25T00:23:25ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8536110.1371/journal.pone.0085361Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.Marian SeifMichael L ImpelidoMichael G AppsNial J WheateThe macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6]uril was formulated into both buffered cream aqueous- and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6]uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery.http://europepmc.org/articles/PMC3893214?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Marian Seif
Michael L Impelido
Michael G Apps
Nial J Wheate
spellingShingle Marian Seif
Michael L Impelido
Michael G Apps
Nial J Wheate
Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
PLoS ONE
author_facet Marian Seif
Michael L Impelido
Michael G Apps
Nial J Wheate
author_sort Marian Seif
title Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
title_short Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
title_full Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
title_fullStr Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
title_full_unstemmed Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
title_sort topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description The macrocycle family of molecules called cucurbit[n]urils are potential drug delivery vehicles as they are able to form host-guest complexes with many different classes of drugs. This study aimed to examine the utility of Cucurbit[6]uril (CB[6]) in topical cream-based formulations for either localised treatment or for transdermal delivery. Cucurbit[6]uril was formulated into both buffered cream aqueous- and oily cream-based dosage forms. The solid state interaction of CB[6] with other excipients was studied by differential scanning calorimetry and the macrocycle's transdermal permeability was determined using rat skin. Significant solid state interactions were observed between CB[6] and the other dosage form excipients. At concentrations up to 32% w/w the buffered aqueous cream maintained its normal consistency and could be effectively applied to skin, but the oily cream was too stiff and is not suitable as a dosage form. Cucurbit[6]uril does not permeate through skin; as such, the results imply that cucurbituril-based topical creams may potentially only have applications for localised skin treatment and not for transdermal drug delivery.
url http://europepmc.org/articles/PMC3893214?pdf=render
work_keys_str_mv AT marianseif topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril
AT michaellimpelido topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril
AT michaelgapps topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril
AT nialjwheate topicalcreambaseddosageformsofthemacrocyclicdrugdeliveryvehiclecucurbit6uril
_version_ 1725357191969374208